Viewing Study NCT01011205


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2025-12-31 @ 6:30 PM
Study NCT ID: NCT01011205
Status: COMPLETED
Last Update Posted: 2024-11-01
First Post: 2009-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
Sponsor: Astellas Pharma Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PMR-EC-1106
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators